ELIE ATA: Open Payments
NPI 1659801520 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,427 in 18 payments from 8 companies in 2025. Trend: 2023 $2,169 · 2024 $1,206 · 2025 $3,427
Consulting: $2,917Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $3,109 |
| Inspire Medical Systems, Inc. | 5 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| PFIZER INC. | 2 | $45 |
| SCPHARMACEUTICALS INC. | 1 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
Products named: Kerendia, INSPIRE, ELIQUIS, FUROSCIX, ENTRESTO, JOURNAVX, DALVANCE, LEQVIO.
Industry payments across MA — which companies pay providers there.
